CompletedNot Applicable

Neuropsychological Development and Executive Functioning of Children Born to HIV- Infected Mothers ( NEUROPSY-HEU )

France32 participantsStarted 2019-11-19

Plain-language summary

Main objective: to evaluate the executive functioning of the HIV exposed uninfected children (HEU) versus children from the same socio-economic and cultural environment, not infected or affected by HIV. Secondary objective (s): to evaluate Intellectual Quotient, Child development, Behavior, Language and investigate link between executive functioning disorders, exposure to ARVs, HIV and family environment.

Who can participate

Age range3 Years – 3 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * experimental: * HIV-positive children born to mothers living with HIV antiretrovirals during pregnancy and in the neonatal period, aged 3 years +/- 3 months on the date of inclusion. * Parents mastering the French. * control: * children, aged 3 years +/- 3 months on the date of inclusion, from the same socio-economic and cultural environment, no infected or affected by HIV. * Parents mastering French. Exclusion Criteria: * great prematurity (28-32 weeks) * genetic anomaly

What they're measuring

evaluate the executive function of children HEU

Timeframe: inclusion

Trial details

NCT IDNCT04108728

SponsorNantes University Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-03-05

View on ClinicalTrials.gov More HIV Infections trials